Related Experiment Video
Updated: Oct 10, 2025

Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Machine Learning to Predict Long-Term Cardiac-Relative Prognosis in Patients With Extra-Cardiac Vascular Disease
Guisen Lin1,2, Qile Liu3, Yuchen Chen3
1Department of Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Insights
Machine learning accurately predicts long-term cardiac events in patients with ischemic stroke, transient ischemic attack, and peripheral artery disease. This approach surpasses traditional risk scores for identifying high-risk individuals needing intensified treatment.
Area of Science:
- Cardiology
- Medical Imaging
- Machine Learning
Background:
- Patients with ischemic stroke (IS), transient ischemic attack (TIA), and peripheral artery disease (PAD) have a higher risk of coronary artery disease.
- Accurate prognostic risk assessment is crucial for identifying high-risk patients who may benefit from intensified treatment.
- Current risk stratification methods for this population remain challenging.
Purpose of the Study:
- To evaluate the feasibility and predictive capability of machine learning (ML) models.
- To predict long-term adverse cardiac outcomes in patients with IS, TIA, and/or PAD.
- To compare ML performance against established clinical risk scores and CCTA metrics.
Main Methods:
- Analysis of 636 patients with a history of IS, TIA, and/or PAD who underwent coronary CT angiography (CCTA).
- Automated feature selection from 35 clinical variables and 34 CCTA metrics for ML model development.
- Clinical outcomes included all-cause mortality (ACM) and major adverse cardiac events (MACE) over a mean follow-up of 3.9 years.
Main Results:
- ML models demonstrated significantly higher predictive accuracy for ACM (AUC 0.92) and MACE (AUC 0.84) compared to modified Duke index, segment stenosis score, segment involvement score, and Framingham risk score.
- Traditional risk scores showed lower predictive values for both ACM and MACE.
- The study identified ML as a superior tool for risk prediction in this patient cohort.
Conclusions:
- Machine learning models show superior capability in predicting long-term adverse cardiac outcomes (ACM and MACE) in patients with IS, TIA, and/or PAD.
- ML surpasses traditional clinical risk scores and CCTA-derived metrics in prognostic accuracy for this high-risk population.
- These findings suggest ML can enhance risk stratification and guide treatment decisions for patients with cerebrovascular and peripheral artery disease.
Abstract:
Aim: Patients with ischemic stroke (IS), transient ischemic attack (TIA), and/or peripheral artery disease (PAD) represent a population with an increased risk of coronary artery disease. Prognostic risk assessment to identify those with the highest risk that may benefit from more intensified treatment remains challenging. To explore the feasibility and capability of machine learning (ML) to predict long-term adverse cardiac-related prognosis in patients with IS, TIA, and/or PAD. Methods: We analyzed 636 consecutive patients with a history of IS, TIA, and/or PAD. All patients underwent a coronary CT angiography (CCTA) scan. Thirty-five clinical data and 34 CCTA metrics underwent automated feature selection for ML model boosting. The clinical outcome included all-cause mortality (ACM) and major adverse cardiac events (MACE) (ACM, unstable angina requiring hospitalization, non-fatal myocardial infarction (MI), and revascularization 90 days after the index CCTA). Results: During the follow-up of 3.9 ± 1.6 years, 21 patients had unstable angina requiring hospitalization, eight had a MI, 23 had revascularization and 13 deaths. ML demonstrated a significant higher area-under-curve compared with the modified Duke index (MDI), segment stenosis score (SSS), segment involvement score (SIS), and Framingham risk score (FRS) for the prediction of ACM (ML:0.92 vs. MDI:0.66, SSS:0.68, SIS:0.67, FRS:0.51, all P < 0.001) and MACE (ML:0.84 vs. MDI:0.82, SSS:0.76, SIS:0.73, FRS:0.53, all P < 0.05). Conclusion: Among the patients with IS, TIA, and/or PAD, ML demonstrated a better capability of predicting ACM and MCAE than clinical scores and CCTA metrics.
More Related Videos
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
Related Concept Videos
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy